The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The use of peptide receptor radionuclide therapy in patients with metastatic low-grade neuroendocrine tumors.
Boris Naraev
No relevant relationships to disclose
Nancy Sharma
No relevant relationships to disclose
Eric Steven Engelman
No relevant relationships to disclose
David L Bushnell
No relevant relationships to disclose
Thomas M. O'Dorisio
No relevant relationships to disclose
Thorvardur Ragnar Halfdanarson
No relevant relationships to disclose